Numbers

Figures converted from Canadian dollars at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

The Numbers

Trican is a WCSB-pure-play pressure pumper priced for exactly what it is: a cyclical Canadian oilfield services name that has earned back its right to compounding discipline but not its right to a premium. Revenue is off its 2011 peak by more than half and still climbing back, but the business today is cleaner — net-debt-free most years, high single-digit FCF yields, dividends and buybacks restarted, margins above the 2011–2014 average despite half the top line. The single metric most likely to rerate (or derate) the stock is EV/EBITDA — at 5.6x it is below the company's 20-year mean near 9.5x and below where US oil services peers trade, and a renewed WCSB completion cycle (LNG-linked gas activity, WCS diff compression) is the thumb on the scale.

A. Snapshot

B. Quality scorecard — can this survive the next downturn?

Trican has rebuilt the balance sheet that nearly killed it in 2015–2016. The scorecard today looks nothing like it did a decade ago.

Two sentences: the Altman Z at 3.89 is the strongest it's been since 2011 and sits comfortably above the 3.0 "safe" line; Piotroski F of 7 out of 9 and a near-zero-debt balance sheet say the company can absorb the next cycle trough without diluting shareholders. The Beneish screen gives no earnings-quality red flag.

C. Revenue & earnings power — a 20-year cycle

The top line tells the Canadian WCSB story: a 2011 boom, a 2015–2016 oil-price collapse, a 2017 Canyon Services acquisition, another 2018–2020 bust (Alberta curtailments, COVID), and a steady 2021–2025 rebuild. FY2025 revenue of $801M is less than half the 2011 peak of $2,262M, but margins are actually similar.

The inflection that matters: since the 2020 trough, operating margin has gone from -16% to a stable 14–17% band and has held there for four consecutive years. That is unusual for this sub-industry and reflects two things — pricing discipline after smaller peers exited the WCSB, and the company running tighter fleet utilization rather than chasing revenue.

Recent direction — last 16 quarters

Q4 2025 was Trican's strongest revenue quarter since 2014, and Q3–Q4 combined ($455M) is the best second half on record since the 2013 downcycle. Spring break-up softness in Q2 is a seasonal feature of the WCSB, not a red flag.

D. Cash generation — are the earnings real?

Over the last five years, cumulative OCF ($589M) runs about 2.4x cumulative net income ($243M) — earnings quality is high and conservative, because D&A (the non-cash expense for a pressure-pumping fleet) is the dominant reconciling item. FCF conversion (FCF / NI) has averaged 106% since 2021, well inside the normal band. Capex has been disciplined at 6–10% of revenue, below the 10–15% range typical in boom years.

E. Capital allocation — buybacks first, then dividend, now acquisitions

Since 2017, Trican has spent roughly $390M on buybacks + dividends on a business that started that period with a $500M+ market cap. The share count is down to ~210M from 322M at the 2018 peak — a real 35% reduction. FY2025 marks a shift: a debt-funded acquisition ($40M) appears alongside the buyback, and the dividend has re-entered the mix at $0.15/share. Allocation discipline has been good, though per-share outcomes depend on whether the acquired assets earn their cost of capital.

F. Balance sheet health

Trican was net-debt-free from 2020–2024. FY2025's $58M net debt is a choice, not a stress signal — it funded the acquisition and a 15c dividend. At 0.3x EBITDA, leverage is a rounding error by industry standards (peers run 0.6x–2.5x), interest coverage is 35x, and the Altman Z at 3.89 is firmly in the safe zone. A full-cycle WCSB downturn remains the risk, but the starting point going in is defensive.

G. Valuation — now vs its own 20-year history

This is the chart that matters.

The 20-year mean EV/EBITDA (positive readings only) is near 9.5x; the 5-year mean is 4.8x; today's 5.6x sits above the post-2020 average but well below the full-cycle norm. Readers should weight both — the 20-year includes boom multiples when WCSB drilling was twice today's level, so reversion to 9.5x is aspirational. A base case of 6.5–7.0x (above post-COVID average but below pre-2014) is the more honest anchor.

At 10.4x trailing earnings with an 8% FCF yield and a 3.5% dividend yield, the market is pricing Trican as a cash-return vehicle, not as a growth re-rate candidate.

H. Peer comparison — the one table that matters

The peer table answers the gap question: Trican trades at a slight premium to the WCSB-pumper cohort (Calfrac, STEP) on EV/EBITDA but at a meaningful discount to the diversified services names (Secure, Enerflex). Among pure pressure pumpers, Trican has the highest ROE (19%), the cleanest balance sheet (0.3x debt/EBITDA), and the only active dividend. The premium is deserved; the discount to diversifiers is structural.

I. Fair value & scenario

Cross-check: the DCF output of $5.76 sits between base and bull. The Graham number ($4.29) and median-P/S implied price ($4.10) sit between bear and base. The asymmetry favours the bull, but only if the WCSB completion cycle and the acquired assets deliver; otherwise investors get a 3.5% dividend and a cheap buyback on a flat earnings run.

What to confirm, contradict, watch

The numbers confirm the rebuild story — balance sheet is clean, margins have stabilized at mid-teens through two years of flat revenue, and the buyback has actually shrunk the share count by a third. They contradict the "FCF is the new steady state" framing promoted by management; Q2 seasonality and four-year-average capex under 8% of revenue together mean a normalized FCF run is more like $60M, not $110M. Watch FY2026 H2: the combination of LNG Canada second-phase capital, AECO gas prices, and fleet utilization will decide whether 2025's $800M revenue is a floor or a ceiling. Any sign of EBITDA margin compression below 18% or debt re-acceleration beyond $110M without an accretive acquisition is the cue to reassess.